These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17298133)

  • 21. Changing patterns in HIV/AIDS stigma and uptake of voluntary counselling and testing services: the results of two consecutive community surveys conducted in the Western Cape, South Africa.
    Mall S; Middelkoop K; Mark D; Wood R; Bekker LG
    AIDS Care; 2013; 25(2):194-201. PubMed ID: 22694602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and control of AIDS: the role of NGOs.
    Sehgal PN
    Health Millions; 1991 Aug; 17(4):31-3. PubMed ID: 12284229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mining industry enters a new era of AIDS prevention. Eye witness: South Africa.
    Heywood M
    AIDS Anal Afr; 1996 Jun; 6(3):16. PubMed ID: 12291113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIDS epidemic in Malawi: shaking cultural foundations.
    Chirwa I
    Netw Res Triangle Park N C; 1993 May; 13(4):31-2. PubMed ID: 12344876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence.
    Creese A; Floyd K; Alban A; Guinness L
    Lancet; 2002 May; 359(9318):1635-43. PubMed ID: 12020523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An unequal activism for an unequal epidemic?
    Selemogo M
    Dev World Bioeth; 2005 May; 5(2):153-68. PubMed ID: 15842724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "I know what I'm facing".
    Jackson H
    Afr Health; 1991 Jul; 13(5):30-1. PubMed ID: 12316916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W; König HH; Schmidt JO; Kalk A
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The economic consequences of AIDS in Africa].
    Ilinigumugabo A
    Afr J Fertil Sexual Reprod Heal; 1996 Dec; 1(2):153-61. PubMed ID: 12321198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The economics of scaling up: cost estimation for HIV/AIDS interventions.
    Kumaranayake L
    AIDS; 2008 Jul; 22 Suppl 1():S23-33. PubMed ID: 18664950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanding the generation and use of economic and financial data to improve HIV program planning and efficiency: a global perspective.
    Holmes CB; Atun R; Avila C; Blandford JM
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S104-8. PubMed ID: 21857291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study: conceptual foundations and overview.
    HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group
    AIDS Care; 2004; 16 Suppl 1():S6-21. PubMed ID: 15739266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caring and government's HIV / AIDS programme.
    Smart R
    Posit Outlook; 1997; 4(2):10-1. PubMed ID: 12293150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstacles to HIV prevention, treatment and care in selected public universities in South Africa.
    Mbatha B
    Afr J AIDS Res; 2014 Sep; 13(3):237-46. PubMed ID: 25388978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mandela calls for greater commitment and leadership in fighting AIDS. The World Economic Forum -- Policy and business in a world of HIV / AIDS.
    Macinnis R
    AIDSlink; 1997; (43):1, 3. PubMed ID: 12321752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporating HIV / AIDS in planning: the Ugandan experience.
    Zedriga CD
    AIDS Anal Afr; 1997 Oct; 7(5):14-5. PubMed ID: 12293008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk analysis. HIV / AIDS country profile: Senegal.
    AIDS Anal Afr; 1996 Dec; 6(6):4-7. PubMed ID: 12320531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health economics in HIV disease. A review of the European literature.
    Youle M; Trueman P; Simpson K
    Pharmacoeconomics; 1999; 15 Suppl 1():1-12. PubMed ID: 10537438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the demand for a preventive HIV vaccine: why we need to do better. Reliable estimates would help in achieving several policy and advocacy objectives.
    Hecht R; Suraratdecha C
    PLoS Med; 2006 Sep; 3(10):e398. PubMed ID: 16953657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Issues of human rights and HIV. Guest commentary.
    Baker AC
    AIDSlink; 1994; (25):6. PubMed ID: 12346134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.